News | December 06, 2022
JB Pharma reduces price of Azmarda by 50%
Move to increase affordability and accessibility for heart failure patients across the country
Move to increase affordability and accessibility for heart failure patients across the country
Asia’s premier and USA-patented, ANSSI Wellness for spinal decompression was launched in Pune
The new eye hospital in Vashi is ASG’s second in the Mumbai Metropolitan Region (MMR) and the sixth in Maharashtra
It offers quick relief in various types of Coughs, Colds and Sore Throat,
The drug will be manufactured at the group’s formulation manufacturing facility at Moraiya, Ahmedabad
With this QIP placement, the Dhanuka group, which took over the company in 2018, is also meeting its mandatory obligation to dilute 15 percent stake in the company by March 2023
Diclofenac Sodium Topical Solution USP, 2% w/w has an estimated market size of US $512 million for twelve months ending Sep 2022 according to IQVIA
Topiramate Extended-Release capsule had annual sales of US $68.8 mn in the United States according to IQVIA data (IQVIA MAT Sep 2022)
Shilpa Medicare Ltd's finished dosage form manufacturing facility, Unit IV, situated at Pharma SEZ, Jadcherla, Telangana has received Health Canada GMP approval
The laboratory has the capacity to conduct 30,000+ tests in a month ranging from simple routine tests to semi-specialized and specialized tests
Subscribe To Our Newsletter & Stay Updated
